Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

BACKGROUND: This pooled analysis investigated the prognostic value of depth of response in two cohorts of patients with BRAF(V600)-mutated metastatic melanoma treated with vemurafenib or cobimetinib plus vemurafenib. METHODS: The data were pooled from BRIM-2, BRIM-3, BRIM-7 and coBRIM. Association o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Karl D., Larkin, James, Ribas, Antoni, Flaherty, Keith T., McArthur, Grant A., Ascierto, Paolo A., Dréno, Brigitte, Yan, Yibing, Wongchenko, Matthew, McKenna, Edward, Zhu, Qian, Mun, Yong, Hauschild, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889491/
https://www.ncbi.nlm.nih.gov/pubmed/31417188
http://dx.doi.org/10.1038/s41416-019-0546-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889491/
https://www.ncbi.nlm.nih.gov/pubmed/31417188
http://dx.doi.org/10.1038/s41416-019-0546-y

Ejemplares similares